The Moderna Vaccine IndexThese companies are selected for composition "Moderna Vaccine" because
1.developed the vaccine
2.suppliers
3.distribution chain
Weights are calculated by relative market cap.
60.37MXN
3.19 BMXN
15.55 BMXN
17.95 M
About LABORATORIOS FARMACEUTOCOS ROVI SA
Sector
CEO
Juan López-Belmonte Encina
Headquarters
Madrid
Website
Employees (FY)
2.11 K
Founded
1946
ISIN
ES0157261019
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ROVI/N is 1455.38 MXN — it has increased by 16.58% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange LABORATORIOS FARMACEUTOCOS ROVI SA stocks are traded under the ticker ROVI/N.
LABORATORIOS FARMACEUTOCOS ROVI SA is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
ROVI/N stock is 14.22% volatile and has beta coefficient of 0.22. Check out the list of the most volatile stocks — is LABORATORIOS FARMACEUTOCOS ROVI SA there?
ROVI/N earnings for the last quarter are 3.18 MXN per share, whereas the estimation was 2.33 MXN resulting in a 36.36% surprise. The estimated earnings for the next quarter are 14.24 MXN per share. See more details about LABORATORIOS FARMACEUTOCOS ROVI SA earnings.
LABORATORIOS FARMACEUTOCOS ROVI SA revenue for the last quarter amounts to 3.94 B MXN despite the estimated figure of 3.88 B MXN. In the next quarter revenue is expected to reach 4.19 B MXN.
Yes, you can track LABORATORIOS FARMACEUTOCOS ROVI SA financials in yearly and quarterly reports right on TradingView.
ROVI/N net income for the last quarter is 965.63 M MXN, while the quarter before that showed 961.48 M MXN of net income which accounts for 0.43% change. Track more LABORATORIOS FARMACEUTOCOS ROVI SA financial stats to get the full picture.
Today LABORATORIOS FARMACEUTOCOS ROVI SA has the market capitalization of 75.74 B, it has increased by 1.64% over the last week.
Yes, ROVI/N dividends are paid annually. The last dividend per share was 19.52 MXN. As of today, Dividend Yield (TTM)% is 1.30%. Tracking LABORATORIOS FARMACEUTOCOS ROVI SA dividends might help you take more informed decisions.
Like other stocks, ROVI/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATORIOS FARMACEUTOCOS ROVI SA stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 2.11 K employees. See our rating of the largest employees — is LABORATORIOS FARMACEUTOCOS ROVI SA on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATORIOS FARMACEUTOCOS ROVI SA technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATORIOS FARMACEUTOCOS ROVI SA stock shows the strong buy signal. See more of LABORATORIOS FARMACEUTOCOS ROVI SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on LABORATORIOS FARMACEUTOCOS ROVI SA future price: according to them, ROVI/N price has a max estimate of 1698.05 MXN and a min estimate of 1095.52 MXN. Read a more detailed LABORATORIOS FARMACEUTOCOS ROVI SA forecast: see what analysts think of LABORATORIOS FARMACEUTOCOS ROVI SA and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LABORATORIOS FARMACEUTOCOS ROVI SA EBITDA is 4.57 B MXN, and current EBITDA margin is 29.39%. See more stats in LABORATORIOS FARMACEUTOCOS ROVI SA financial statements.